Mayne Pharma Group Limited MAYNF
2.27 USD 0.00 (+0.00%)
At closeNov 11, 2026, 4:00 PM EST
1.87 Day range 1.87
1.40 52-week range 3.90
- YTD
- +9.42%
- 1 year
- -26.94%
News
seekingalpha.com Mayne Pharma Group Limited (MAYNF) M&A Call Transcript Mayne Pharma Group Limited (MAYNF) M&A Call Transcript
defenseworld.net Mayne Pharma Group (OTCMKTS:MAYNF) Shares Down 8.8% – What’s Next? Mayne Pharma Group Limited (OTCMKTS:MAYNF - Get Free Report) shares traded down 8.8% during mid-day trading on Friday. The stock traded as low as $1.87 and last traded at $1.87. 8,135 shares traded…
seekingalpha.com Mayne Pharma Group Limited (MAYNF) Q4 2026 Earnings Call Transcript Mayne Pharma Group Limited (MAYNF) Q4 2026 Earnings Call Transcript
defenseworld.net Contrasting Otsuka (OTCMKTS:OTSKY) and Mayne Pharma Group (OTCMKTS:MAYNF) Mayne Pharma Group (OTCMKTS:MAYNF - Get Free Report) and Otsuka (OTCMKTS:OTSKY - Get Free Report) are both medical companies, but which is the superior investment? We will contrast the two businesses…
seekingalpha.com Mayne Pharma Group Limited (MAYNF) Discusses U.S. Launch and Business Model of DistributeRx Transcript Mayne Pharma Group Limited (MAYNF) Discusses U.S. Launch and Business Model of DistributeRx Transcript
seekingalpha.com Mayne Pharma Group Limited (MAYNF) Q2 2026 Earnings Call Transcript Mayne Pharma Group Limited (MAYNF) Q2 2026 Earnings Call Transcript
defenseworld.net Mayne Pharma Group (OTCMKTS:MAYNF) Stock Price Up 1.4% – Should You Buy? Mayne Pharma Group Limited (OTCMKTS:MAYNF - Get Free Report)'s stock price was up 1.4% on Thursday. The stock traded as high as $1.8550 and last traded at $1.8550. Approximately 731 shares were…
seekingalpha.com Mayne Pharma Group Limited (MAYNF) Shareholder/Analyst Call Transcript Mayne Pharma Group Limited (MAYNF) Shareholder/Analyst Call Transcript
defenseworld.net Mayne Pharma Group (OTCMKTS:MAYNF) Shares Down 9.7% – Here’s What Happened Mayne Pharma Group Limited (OTCMKTS:MAYNF - Get Free Report)'s stock price fell 9.7% on Monday. The stock traded as low as $2.13 and last traded at $2.13. 150 shares changed hands during mid-day…
businesswire.com Termination of Proposed Acquisition of Mayne Pharma BRIDGEWATER, N.J.--(BUSINESS WIRE)--Cosette Pharmaceuticals, Inc. (Cosette), a U.S.-based, fully integrated pharmaceutical company, confirms that on 9 December 2025 it served a notice on Mayne Pharma…
wsj.com Australia Blocks U.S.-Based Cosette's $387.2 Million Takeover of Mayne Pharma Australia's government said it would block a $387.2 million takeover of Mayne Pharma by U.S. company Cosette Pharmaceuticals on national security grounds, citing a need to protect critical medical…
reuters.com Australia blocks Cosette Pharmaceuticals bid to buy Mayne Pharma Australia on Friday blocked a A$672 million ($433 million) buyout offer for Mayne Pharma from U.S. drugmaker Cosette Pharmaceuticals, citing national interest.
reuters.com Australia's Mayne Pharma falls as treasurer considers blocking Cosette's $437 million bid Australia's Mayne Pharma said on Friday it had received a letter from its potential acquirer, Cosette, indicating that the country's treasurer is considering blocking the A$672 million ($436.67…
reuters.com Cosette's attempt to drop $438 million Mayne Pharma deal denied by court An Australian court has moved to prevent U.S. drugmaker Cosette Pharmaceuticals from abandoning its A$672 million ($437.6 million) acquisition of Mayne Pharma , the ASX-listed company said on…
reuters.com Mayne Pharma slumps 30% as Cosette threatens to scrap $432 million deal Shares of Mayne Pharma plunged 30% on Wednesday after U.S.-based Cosette Pharmaceuticals initiated a review of its A$672 million ($432.1 million) acquisition, citing a "material adverse change" in…
businesswire.com Cosette Pharmaceuticals Announces Acquisition of Mayne Pharma, Transforming Company into a Leader in Women's Health and Dermatology BRIDGEWATER, N.J.--(BUSINESS WIRE)--Cosette Pharmaceuticals, Inc., a U.S.-based, fully integrated, pharmaceutical company, announced today that it has entered into a definitive agreement to acquire…
prnewswire.com FEDERAL CONTRACEPTION PROPOSAL TO EXPAND ACCESS AND AFFORDABLE COVERAGE PAVES A STRONGER PATH FOR MAYNE PHARMA'S GROWTH IN WOMEN'S HEALTH Proposed Ruling Aims to Eliminate Out-of-Pocket Costs for Contraception, Enhancing Access for Women in the United States ADELAIDE, Australia and RALEIGH, N.C. , Nov. 4, 2024 /PRNewswire/ -- Mayne…
reuters.com Australia's Mayne Pharma sues Indian drugmaker Sun Pharma over patent infringement Mayne Pharma has filed a patent infringement lawsuit against Indian drugmaker Sun Pharma in a U.S. court, the Australian drugmaker said on Thursday.
seekingalpha.com Mayne Pharma Group Limited (MAYNF) Q2 2024 Earnings Call Transcript Mayne Pharma Group Limited (OTCPK:MAYNF) Q2 2024 Results Conference Call February 25, 2024 5:00 PM ET
benzinga.com Stocks That Hit 52-Week Lows On Tuesday 
benzinga.com Stocks That Hit 52-Week Lows On Wednesday 
benzinga.com Stocks That Hit 52-Week Lows On Friday